The Daily Papule

Meeting abstracts

BAD 2026

British Association of Dermatologists · Manchester, 30 June – 2 July 2026

639 abstracts, published in BJD on 26 June 2026.

  1. AI08

    Validation of the EczemaNet artificial intelligence-based eczema severity tool in a paediatric population

    Gavin Fong WC, Strawford J, … senior author Thomas K

  2. AI15

    Dermatology on social media: an analysis of influencer content on atopic dermatitis and topical steroid withdrawal

    Al-Temimi D, Gkini M

  3. BG03

    Atopic eczema in older adults: findings from the UK-Irish Atopic eczema Systemic therapy Register (A-STAR)

    Gawkrodger DJ, Tsoi MF, … senior author Flohr C

  4. BG14

    Refractory pruritus in older patients: a case of prebullous pemphigoid mimicking folliculitis and generalized eczema

    Kongala Arachchige IP, Burova K, … senior author Tan J

  5. BI03

    An out-of-place mucosal virus causing cutaneous crisis: a rare case of disseminated human papillomavirus-6 infection during upadacitinib therapy for atopic dermatitis

    Moon E, Shanshal M

  6. BI38

    Methotrexate-associated lymphoma in atopic dermatitis: two case reports

    Eid D, Ponnambath N

  7. BI40

    Prevalence of Strongyloides seropositivity in patients with eczema requiring biologic therapy in a UK multisite trust

    Ngai A, Cunningham M, … senior author Mehrtens S

  8. BI43

    A high-risk squamous cell carcinoma developing in a patient with eczema treated with upadacitinib

    Murphy L, McCafferty B, … senior author McKenna D

  9. CD07

    Benzyl alcohol as a clinically relevant excipient allergen: a case series from a tertiary cutaneous allergy centre

    Khan T, Thompson D

  10. CD24

    Case series: pitfalls of implanted metals

    Fuller J, Nixon R

  11. CPC01

    Diagnostic challenge of chronic urticarial vasculitis: unmasking VEXAS syndrome in an older man

    Odedra J, Baloch H, Shah S

  12. CPC09

    Trichodysplasia spinulosa masquerading as seborrhoeic dermatitis in a renal transplant recipient

    Bali R, Elshimy N

  13. GD05

    Outcomes from a global–national partnership: 18 months of the Global Atopic Dermatitis Atlas and the Lebanese Registry for Atopic Dermatitis

    Allen P, Iskandar R, … senior author El Khoury Okais J

  14. HX23

    Battlefield to bathwater: the evolution of sodium hypochlorite in dermatology

    Wong V, Bhandari S, Ngee Shim T

  15. LY02

    Dupilumab use in atopic dermatitis when cutaneous lymphoma is suspected: consensus recommendations from the EORTC Cutaneous Lymphoma Tumour Group

    Calvão J, Gonçalo M, … senior author Guenova E

  16. O05

    Drug survival of dupilumab, methotrexate and ciclosporin in patients with atopic eczema: results from the UK-Irish Atopic eczema Systemic TherApy Register (A-STAR)

    Gribaleva E, Tsoi MF, … senior author Flohr C

  17. O08

    The aryl hydrocarbon receptor pathway is differentially regulated in psoriasis and atopic dermatitis with implications for therapeutic intervention

    Dawe H, Ashoori MD, … senior author Di Meglio P

  18. O09

    Drug reaction with eosinophilia and systemic symptoms (DRESS) eosinophil transcriptomes show distinct interleukin-5 and interleukin-3 regulation compared with atopic dermatitis and asthma

    Dezoteux F, Clayton K, … senior author Ardern-Jones MR

  19. O12

    Efficacy of ruxolitinib cream for the treatment of moderate atopic dermatitis across anatomic regions in the phase IIIb TRuE-AD4 study

    Agius E, Peris K, … senior author Eleftheriadou V

  20. P004

    Digital dermatology: influence of online content on disease beliefs, anxiety and treatment behaviour in atopic dermatitis, topical steroid withdrawal and psoriasis

    Al-Temimi D, Bewley A, Gkini M

  21. P031

    Granulomatous eruptions in patients treated with dupilumab

    Allotey B, Pattle S, Sergeant A

  22. P049

    A well-behaved ulcer: Epstein–Barr virus-positive mucocutaneous ulcer mimicking lymphoma in an immunosuppressed dermatology patient

    Hogg E, Zaki I, … senior author Sihota H

  23. P070

    Setting up a Nurse-Led Atopic Dermatitis (NuLAD) service

    Qasem N, Sandhu S, … senior author Fremlin G

  24. P079

    Analysis of cumulative life course impairment in tertiary atopic dermatitis care: insights from the first use of the DermCLCI-r questionnaire in an English cohort

    Matthews R, Stuhlmann C, … senior author Warren RB

  25. P088

    Reasons for new patient attendances in general dermatology clinics in a secondary care service

    Aval LM, Patel NP

  26. P104

    Optimizing dupilumab initiation through standardized prescreening: a quality improvement project

    Mackender E, Petrou IA, Ali M

  27. P105

    Sustained use of topical tacrolimus for seborrhoeic dermatitis: revisiting cancer risk in light of chronic inflammatory control – a meta-analysis

    Ojo E, Oyibo S, … senior author Onobun D

  28. P106

    A national survey exploring experiences of eczema, acne and psoriasis across different ethnic groups in the UK

    Hutchison E, Granell R, … senior author Ridd M

  29. P114

    The cost of caution: evaluating the utility and financial impact of procollagen-3 N - terminal peptide monitoring in methotrexate-treated patients

    Pallippattu AW, Anandbabu R, … senior author Yesudian PD

  30. P119

    Recognise 1: exploring the association between itch and therapeutic choice in atopic dermatitis

    Shams K, Laws P, … senior author Guirguis D

  31. P120

    Improvements in signs of chronic hand eczema with delgocitinib cream as assessed by the Hand Eczema Symptom Diary: pooled analysis of the phase III DELTA 1 and 2 trials

    Warren RB, Johnston GA, … senior author Woolf R

  32. P123

    The association of (hyper)eosinophilia with atopic dermatitis severity and treatment response: evidence from the UK-Irish Atopic eczema Systemic TherApy Register (A-STAR)

    Dezoteux F, Tsoi MF, … senior author Ardern-Jones MR

  33. P126

    Treatment journey in patients with atopic dermatitis on abrocitinib: real-world evidence from the DREAM TO TREAT AD (D2T AD) Consortium

    Prieto-Merino D, Gribaleva E, … senior author Flohr C

  34. P127

    Impact of minimal disease activity on quality of life in patients with atopic eczema: results from the UK-Irish Atopic eczema Systemic TherApy Register (A-STAR)

    Tsoi MF, Gribaleva E, … senior author Flohr C

  35. P132

    Safety and effectiveness of tralokinumab treatment in adults with atopic dermatitis who previously discontinued dupilumab due to the adverse event conjunctivitis: 12-months real-world data from the TRACE study

    Armstrong AW, Rubin C, … senior author Thaçi D

  36. P133

    Improvements in sleep among people with atopic dermatitis: a systematic review of randomized clinical trial evidence and outcomes for biologic treatments

    Flohr C, Wan M, … senior author Watkins M

  37. P145

    Lebrikizumab demonstrates significant efficacy and stable long-lasting response in patients with atopic dermatitis with skin of colour

    Ardern-Jones MR, Alexis A, … senior author Waibel J

  38. P149

    Efficacy of lebrikizumab at 16 weeks: pooled analyses from the ADvocate1 and ADvocate2 phase III trials in adolescent and older adult patients with moderate-to-severe atopic dermatitis

    Flohr C, Hebert A, … senior author Weidinger S

  39. P150

    Atopic dermatitis disease control with nemolizumab: subgroup analysis of the ARCADIA LTE

    Pink A, Warren RB, … senior author Rout R

  40. P152

    Baseline characteristics and treatment effectiveness of abrocitinib in moderate-to-severe atopic dermatitis: results from the UK-Irish Atopic eczema Systemic TherApy Register (A-STAR) cohort analysis

    Raymond B, Patel M, Sahin B

  41. P153

    Tertiary clinic experience of weekly dupilumab in atopic dermatitis

    Johnston S, Dickson D, … senior author MacDonald A

  42. P154

    Patient perceptions and preferences regarding systemic medicines for moderate-to-severe eczema

    Harvey J, Shall E, … senior author Leighton P

  43. P158

    Efficacy of dupilumab in the treatment of atopic dermatitis in the head and neck region: a systematic review

    Park YS, Nguyen T, … senior author Yew YW

  44. P169

    Children with active atopic dermatitis and sleep disturbance have a greater risk of mental health conditions: a retrospective matched cohort study in England

    Flohr C, Wan M, … senior author Watkins M

  45. P172

    Compassionate use of dupilumab in infants and young children aged 6 months to 6 years with severe atopic dermatitis: a retrospective case series

    Al-Darrajy H, Cork MJ

  46. P176

    ‘I didn’t want to be a darker shade of me’: a qualitative study exploring experiences of eczema, acne and psoriasis in people with skin of colour in the UK

    Hutchison E, Parslow R, … senior author Ridd M

  47. P179

    The importance of the combined approach (habit reversal therapy and topical treatment) in the management of atopic dermatitis: a retrospective observational analysis of website usage data

    Abid H, Farooq S, Ahmed A

  48. P183

    APG777, a novel, half-life-extended anti-interleukin-13 antibody, demonstrates safety and efficacy in moderate-to-severe atopic dermatitis: 16-week results from the phase II APEX study

    Guttman-Yassky E, Blauvelt A, … senior author Silverberg J

  49. PA06

    Prescribing practices of methotrexate in a general paediatric dermatology department: a two-cycle retrospective audit (2018–2025)

    Aziz S, Shah S, … senior author Flohr C

  50. PA09

    Persistent barrier dysfunction in lesional atopic dermatitis despite clinical improvement

    Briggs E, Ibzea S, … senior author Ardern-Jones MR